Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer

Cancer Epidemiology Biomarkers and Prevention · Published 2026-05-12 · DOI 10.1158/1055-9965.epi-25-2004

Free full text

Authors (29)

Kevin C. McGann, Palina Woodhouse, Heidi Chen, Michael N. Kammer, Hudson Michael Holmes, Camden Lopez, Harvey I. Pass, Jun-Chieh J. Tsay, Marc E. Lenburg, Steven M. Dubinett, James C. Willey, James G. Herman, Matthew B. Schabath, Timothy A. Khalil, Yong Zou, Melissa H. Potter, Sheau-Chiann Chen, Samson A. Argaw, Patrick Meyers, Sam Fischer, Carolyn Tran, Yency J. Forero, Sanja Antic, Rafael Paez, Eardi Lila, Anna E. Barón, Fabien Maldonado, Stephen A. Deppen, Eric L. Grogan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

McGann, K., Woodhouse, P., Chen, H., et al. (2026). Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer. Cancer Epidemiology Biomarkers and Prevention. https://doi.org/10.1158/1055-9965.epi-25-2004

Related articles

• The Importance of Minority Stress and Intersectionality for Cancer Symptom Management: The Case of Cancer-Related Pain · Cancer Epidemiology Biomarkers and Prevention · 2026 · Same journal
• Interval from Cancer Diagnosis to Depression Onset and Risk of Dementia in Cancer Survivors · Cancer Epidemiology Biomarkers and Prevention · 2026 · Same journal
• Low Muscle Density Is Associated with Morbidity and Systemic Inflammation in Colorectal Cancer, Independent of Tumor Factors · Cancer Epidemiology Biomarkers and Prevention · 2026 · Same journal
• Patterns of Multimorbidity among Older Adults with Colorectal Cancer Living in Puerto Rico · Cancer Epidemiology Biomarkers and Prevention · 2026 · Same journal
• Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression · Cancer Epidemiology Biomarkers and Prevention · 2026 · Same journal
• Sex Differences in Cancer Stage at Diagnosis of Nonreproductive Solid Organ Tumors in the United States, 2015 to 2022 · Cancer Epidemiology Biomarkers and Prevention · 2026 · Same journal
• Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: An Evaluation of the COVID-19 Pandemic · Cancer Epidemiology Biomarkers and Prevention · 2026 · Same journal
• The effectiveness of Incentives on Cancer Screening Among Indigenous Populations: Systematic Review · Cancer Epidemiology Biomarkers and Prevention · 2026 · Same journal
• A Quantitative Framework to Assess the Potential of Earlier Cancer Detection to Improve Cancer Survival · Cancer Epidemiology Biomarkers and Prevention · 2026 · Same journal
• Helicobacter pylori Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis · Cancer Epidemiology Biomarkers and Prevention · 2026 · Same journal